Skip to main content

Table 2 Indication for warfarin anticoagulation reversal

From: Comparison of 3-Factor Prothrombin Complex Concentrate and Low-Dose Recombinant Factor VIIa for Warfarin Reversal

  Characteristics

PCC3 (n = 74)

LD rFVIIa (n = 32)

p

Neuro, n*

39

23

0.07

  CH

19

9

0.79

  SDH

7

9

0.014

  SAH

6

2

1.00

  SCI

1

2

0.22

  TBI

6

1

0.67

  Craniotomy

0

1

0.30

Abdominal

11

3

0.55

  Intraperitoneal Hem.

2

0

1.00

  Retroper. hematoma

1

0

1.00

  GIB

2

1

1.00

  Perf. Viscous/

0

1

0.30

  peritonitis

   

  Pneumoperitoneum

1

0

1.00

  Incarcerated hernia

2

1

1.00

  Acute abdomen

1

0

1.00

  Diverticulitis

1

0

1.00

  Colonic perforation

1

0

1.00

Other

25

8

0.37

  Orthopedic

2

3

0.16

  Fall w/external inj.

0

1

0.30

  Multiple trauma

0

1

0.30

  Pulmonary contusion

1

0

1.00

  Chest wall trauma

1

0

1.00

  Pacemaker placement

2

0

1.00

  Emergent surgery

4

1

1.00

  Ruptured iliac

1

0

1.00

  Artery aneurysm

   

  Pseudoaneurysm

1

0

1.00

  CFA

   

  Hematoma

3

0

1.00

  Pneumothorax

2

0

1.00

  Posthemorrhagic

1

0

1.00

  Hydrocephalus

   

  Epistaxis

0

1

0.30

  INR > 8

6

0

0.18

  Unknown

1

0

1.00

  1. *1 with more than 1 indication.
  2. PCC3, 3 factor prothrombin complex concentrate; LDrFVIIa, low dose recombinant factor VII activated; ICH, intracranial hemorrhage, SDH, subdural hematoma, SAH, subarachnoid hemorrhage, SCI, spinal cord injury, TBI, traumatic brain injury, GIB, gastrointestinal bleed, CVA, cerebral vascular accident; DVT, deep vein thrombosis; PE, pulmonary embolism.